Overall Survival and Response to Systemic Therapy in Metastatic Extrauterine Leiomyosarcoma
Background. Leiomyosarcomas (LMS) represent a heterogeneous subset of soft tissue sarcomas. Factors influencing prognosis for patients with metastatic extrauterine LMS (euLMS) are not well described. Limited data are available regarding responses to systemic therapy. Methods. We collected clinical a...
Main Authors: | A. N. Shoushtari, J. Landa, D. Kuk, A. Sanchez, B. Lala, N. Schmidt, C. Okoli, P. Chi, M. A. Dickson, M. M. Gounder, M. L. Keohan, A. M. Crago, W. D. Tap, S. P. D’Angelo |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Sarcoma |
Online Access: | http://dx.doi.org/10.1155/2016/3547497 |
Similar Items
-
Phase II Study of Temozolomide and Thalidomide in Patients with Unresectable or Metastatic Leiomyosarcoma
by: Michelle S. Boyar, et al.
Published: (2008-01-01) -
An extrauterine extensively metastatic epithelioid trophoblastic tumor responsive to pembrolizumab
by: Sarah G. Bell, et al.
Published: (2021-08-01) -
Extrauterine growth restriction: is it preventable?
by: Richard A. Ehrenkranz
Published: (2014-01-01) -
Extrauterine growth restriction: Is it preventable?
by: Richard A. Ehrenkranz
Published: (2014-01-01) -
Influence of intrauterine and extrauterine growth on neurodevelopmental outcome of monozygotic twins
by: R.K. Reolon, et al.
Published: (2008-08-01)